Clinical characteristics of a COVID-19 cohort treated at UCLA Ronald Reagan Medical Center during the breaking phase of the pandemic: A retrospective study
Age, Anti-virals, Antibiotics, Body mass index, BMI, COVID‐19, California, Census, Coagulation, Demography, Ethnicities, Gender, Immunosuppressants, Inflammation, Intensive care/intensive care unit, Los Angeles, Obesity, Pandemic, Public health, Ronald Reagan Medical Center, SARS-COV-2, Smoking, Steroids, University of California Los Angeles, UCLA,
Related Posts
Cai X, White Q, Juarez J, Chehab O, Ambale-Venkatesh B, Johnson WC, Hansen SL, Inoue K, Lima JAC, Watson KE, McClelland RL. Association of Subclinical[...]
Krishnareddigari M, Joodi G, Zinoviev RI, Yarra S, Aksoy O. Improved hemodynamic performance and reduced paravalvular regurgitation with the SAPIEN 3 Ultra RESILIA valve: a[...]
Roman S, Budoff MJ. Effect of Omega-3 fatty acids, fibrates and PCSK9 inhibitors on atherosclerotic plaque burden, composition and stability: Insights from imaging. Pharmacol Ther.[...]